Cryopreserved Amniotic Membrane in The Management of Persistent Epithelial Defect
Amniotic membrane has anti-inflammatory, anti-scarring and anti-angiogenic properties. Preclinical and clinical evidence support the successful use of cryopreserved amniotic membrane in treating corneal epithelial defects and ulcers caused by neurotrophic keratitis and the ulcers which are unrespons...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.7869/djo.746 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Amniotic membrane has anti-inflammatory, anti-scarring and anti-angiogenic properties. Preclinical and clinical evidence support the successful use of cryopreserved amniotic membrane in treating corneal epithelial defects and ulcers caused by neurotrophic keratitis and the ulcers which are unresponsive to prior treatment. The case describes one such use of amniotic membrane in the treatment of a persistent epithelial defect. |
|---|---|
| ISSN: | 0972-0200 2454-2784 |